Search results
Results from the WOW.Com Content Network
The top 5 best selling pharmaceuticals 2015–2019. Sales in billion USD. [1] Rank Drug ... The top 16 best selling pharmaceuticals of 2017/18. [2] Rank Drug
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
As of 2015, several pharmaceutical companies had developed a new business strategy "of dominating noncompetitive markets for older drugs and then increasing the price substantially". [65] In 2019 alone the price of over 3,400 drugs increased. [66] For instance, Allergan raised prices on 51 drugs, just more than half its total medications.
There are tough competitors across the board for Johnson & Johnson's best-selling pharmaceuticals. From big pharma's biggest players such as Pfizer and Merck to small-time biotech companies like ...
Also, Synthroid can't possibly be the #1 top selling drug. I'd be surprised if it is currently in the top 50. -- Ed 13:23, 8 October 2015 (UTC) For now, I have reverted to an older version of the article. Incorrect data appears to have been added in Aug 2015. -- Ed 11:34, 5 December 2015 (UTC)
The headquarters of Pfizer in Tokyo, Japan. Pfizer Inc. (/ ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F ...
It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. [7]
The best-selling drugs list published by Genetic Engineering & Biotechnology News, shows that Humira occupied the #1 position for 2015 (US$14.012 billion) and 2016 (US$16.078 billion) [99] From 2012 until the US patent expired in 2016, Humira led the list of top-selling pharmaceutical products, and in 2016, it had US$16 billion of global sales ...